Breaking News Instant updates and real-time market news.

GOOG

Alphabet

$1,194.79

0.62 (0.05%)

, GOOGL

Alphabet Class A

$1,207.07

-0.23 (-0.02%)

06:14
10/02/18
10/02
06:14
10/02/18
06:14

Google's advertising chief Sridhar Ramaswamy leaving to join Greylock

Google's longtime advertising chief is leaving after 15 years to join Greylock, the VC firm said in a post on Medium. Sridhar Ramaswamy is leaving to join the venture capital firm, and will be replaced by Prabhakar Raghavan, vice president of Engineering at Google. Reference Link

GOOG

Alphabet

$1,194.79

0.62 (0.05%)

GOOGL

Alphabet Class A

$1,207.07

-0.23 (-0.02%)

  • 03

    Oct

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 07

    Nov

  • 03

    Mar

GOOG Alphabet
$1,194.79

0.62 (0.05%)

09/27/18
JMPS
09/27/18
NO CHANGE
JMPS
JMP says battle lines drawn with Salesforce on one side, Microsoft on other
After attending Salesforce's (CRM) analyst day hosted in conjunction with the Dreamforce user conference, Patrick Walravens noted that the event "happens to coincide" with Microsoft's (MSFT) Ignite conference in Orlando. He said the most interesting new development in the competitive landscape is the way the "battle lines are being drawn" between Salesforce, Google (GOOGL) and Amazon (AMZN), which announced new strategic relationships this week, and Microsoft, SAP (SAP) and Adobe (ADBE), who announced the Open Data Initiative on September 24, on the other side. In terms of product highlights from Dreamforce, Chief Product Officer Bret Taylor highlighted Customer 360 and Einstein Voice, said Walravens, who keeps an Outperform rating and $178 price target on Salesforce shares.
09/27/18
KEYB
09/27/18
NO CHANGE
Target $1430
KEYB
Google Other Segment breakout suggests gross margin upside, says KeyBanc
KeyBanc analyst Andy Hargreaves says his breakout of the components of Google "other" revenue and estimated margins suggests his forward gross margin expectations were conservative. Furthermore, Hargreaves believes growth in Cloud and Play are underappreciated. The analyst reiterates an Overweight rating and $1,430 price target on Alphabeth's class A shares.
09/25/18
MSCO
09/25/18
NO CHANGE
Target $2500
MSCO
Overweight
Amazon should increase focus on autonomous driving, says Morgan Stanley
Morgan Stanley analyst Brian Nowak makes the case that autonomous driving technology should be where Amazon (AMZN) invests next, stating that Alphabet's (GOOGL) Waymo partnering with Walmart (WMT) and shopping center owner DDR (DDR) to drive shoppers to stores is "just the beginning." He sees the potential for a deeper integration between Google Shopping and Waymo autonomous cars to deliver retailers' in-store or warehouse inventory to consumers, and sees Amazon needing a defense against a stronger potential long-term Waymo retail offering. Nowak also notes that Amazon is already investing in its own delivery network and contends that investing in an autonomous offering is just an extension of this strategy in many ways. Additionally, the analyst sees a small relative upfront investment, the potential for large shipping savings and ways to leverage the value of miles driven. Nowak maintains an Overweight rating and $2,500 price target on Amazon shares.
09/25/18
NOMU
09/25/18
NO CHANGE
Target $125
NOMU
Buy
Square price target raised to $125 from $86 at Nomura Instinet
Nomura Instinet analyst Dan Dolev raised his price target for Square (SQ) to $125 from $86 and keeps a Buy rating on the shares. The stock closed yesterday up 75c to $86.04. The analyst's analysis of Square's fundamentals indicates "buoyant" gross payment volume, revenue and marketing efficacy trends. The company's "fully cohesive solutions and rapid rate of innovation" suggest that it is en route to disrupt the global payments ecosystem, Dolev tells investors in a research note titled "Improving Momentum Means $125 Is Within Reach." He believes this is similar to the FANG stocks, or Facebook (FB), Amazon.com (AMZN), Netflix (NFLX) and Google (GOOG, GOOGL), that have "disrupted traditional markets with massive" global total addressable markets. Further, Dolev believes shares of Square are not too expensive when taking into account its "stellar" 45% expected three-year annual revenue growth, which he thinks "makes it screen more attractively than many payment peers and FANG stocks."
GOOGL Alphabet Class A
$1,207.07

-0.23 (-0.02%)

09/25/18
RBCM
09/25/18
NO CHANGE
Target $10
RBCM
Outperform
Competing big for Pandora 'unlikely', says RBC Capital
RBC Capital analyst Mark Mahaney kept his Outperform rating and $10 price target on Pandora (P) after yesterday's announcement of a pending acquisition by Sirius (SIRI). The analyst believes that this is a "logical strategic step" based on the potential synergies between the two, with the first having a very strong in-home presence and the latter a very strong in-car presence. Mahaney also sees the $10.14 per share acquisition price as very reasonable and consistent with his own price target derived from 1.5-times multiple of forward price to sales. The analyst further notes that a competing bid from potential other acquirers like Spotify (SPOT), Apple (AAPL), Google (GOOGL), and Amazon (AMZN) is "reasonable unlikely at this point".

TODAY'S FREE FLY STORIES

EA

Electronic Arts

$99.25

-3.73 (-3.62%)

, ATVI

Activision Blizzard

$43.82

-0.66 (-1.48%)

12:35
02/20/19
02/20
12:35
02/20/19
12:35
On The Fly
Game On: An exclusive talk with Beamdog CEO Trent Oster »

'NEVERWINTER NIGHTS'…

EA

Electronic Arts

$99.25

-3.73 (-3.62%)

ATVI

Activision Blizzard

$43.82

-0.66 (-1.48%)

TTWO

Take-Two

$89.77

-3.52 (-3.77%)

NTDOY

Nintendo

$0.00

(0.00%)

MSFT

Microsoft

$106.99

-0.77 (-0.71%)

SNE

Sony

$46.86

0.65 (1.41%)

TCEHY

Tencent

$0.00

(0.00%)

UBSFY

Ubisoft

$0.00

(0.00%)

CCOEY

Capcom

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 03

    Mar

  • 04

    Mar

  • 04

    Mar

  • 06

    Mar

  • 07

    Mar

  • 12

    Mar

  • 13

    Mar

  • 18

    Mar

12:35
02/20/19
02/20
12:35
02/20/19
12:35
General news
FOMC minutes preview: the minutes will be scrutinized »

FOMC minutes preview: the…

OSPN

OneSpan

$20.13

3.355 (20.00%)

12:33
02/20/19
02/20
12:33
02/20/19
12:33
Downgrade
OneSpan rating change  »

Imperial downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 11

    Mar

  • 12

    Mar

  • 28

    Mar

OSPN

OneSpan

$20.21

3.435 (20.48%)

12:28
02/20/19
02/20
12:28
02/20/19
12:28
Downgrade
OneSpan rating change  »

OneSpan downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 11

    Mar

  • 12

    Mar

  • 28

    Mar

KMI

Kinder Morgan

$19.20

0.05 (0.26%)

12:27
02/20/19
02/20
12:27
02/20/19
12:27
Hot Stocks
Kinder Morgan Chairman Richard Kinder buys over 19K shares of company stock »

Kinder Morgan Chairman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

NYT

New York Times

$32.02

0.06 (0.19%)

12:25
02/20/19
02/20
12:25
02/20/19
12:25
Hot Stocks
New York Times publisher responds to Trump's 'enemy of the people' tweet »

After President Trump…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

RTTR

Ritter Pharmaceuticals

$0.66

-0.0104 (-1.55%)

12:25
02/20/19
02/20
12:25
02/20/19
12:25
Conference/Events
Ritter Pharmaceuticals to host conference call »

Expert call with Dr Chey,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

ZNGA

Zynga

$5.09

-0.01 (-0.20%)

12:20
02/20/19
02/20
12:20
02/20/19
12:20
Options
Defensive option play in Zynga as shares ease off 52-week highs »

Defensive option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 11

    Mar

  • 11

    Mar

HSY

Hershey

$109.97

0.275 (0.25%)

12:19
02/20/19
02/20
12:19
02/20/19
12:19
Earnings
Hershey issues long-term adjusted EPS growth target of 6%-8% »

Hershey in conference…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 03

    Mar

MCS

Marcus

$40.59

1 (2.53%)

12:18
02/20/19
02/20
12:18
02/20/19
12:18
Hot Stocks
Marcus raises quarterly dividend 6.7% to 16c per share »

Directors of The Marcus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 02

    Apr

  • 02

    Apr

  • 06

    Jun

HSY

Hershey

$109.95

0.255 (0.23%)

12:18
02/20/19
02/20
12:18
02/20/19
12:18
Hot Stocks
Hershey would consider debt to EBITDA ratio over 2.0 times for acquisition »

Hershey in conference…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 03

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
02/20/19
02/20
12:17
02/20/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
02/20/19
02/20
12:16
02/20/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:15
02/20/19
02/20
12:15
02/20/19
12:15
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

CVS

CVS Health

$64.92

-5 (-7.15%)

, TSLA

Tesla

$302.25

-3.31 (-1.08%)

12:11
02/20/19
02/20
12:11
02/20/19
12:11
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks opened little…

CVS

CVS Health

$64.92

-5 (-7.15%)

TSLA

Tesla

$302.25

-3.31 (-1.08%)

BMY

Bristol-Myers

$51.21

-0.14 (-0.27%)

CELG

Celgene

$91.25

0.54 (0.60%)

KNDI

Kandi Technologies

$8.45

2.52 (42.50%)

GRMN

Garmin

$82.11

11.145 (15.71%)

NVTA

Invitae

$18.55

2.06 (12.49%)

OMI

Owens & Minor

$6.48

-1.46 (-18.39%)

WIX

Wix.com

$110.43

-15.275 (-12.15%)

CXO

Concho Resources

$114.44

-6.51 (-5.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 21

    Feb

  • 22

    Feb

  • 22

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 27

    Feb

  • 27

    Feb

  • 28

    Feb

  • 12

    Mar

  • 18

    Mar

  • 18

    Mar

  • 19

    Mar

  • 18

    May

  • 20

    May

  • 22

    May

  • 28

    May

HSY

Hershey

$110.01

0.315 (0.29%)

12:09
02/20/19
02/20
12:09
02/20/19
12:09
Hot Stocks
Hershey reaffirms 2019 guidance at CAGNY Conference »

Hershey said that in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 03

    Mar

KNX

Knight-Swift

$34.96

0.73 (2.13%)

12:05
02/20/19
02/20
12:05
02/20/19
12:05
Options
Knight Transportation call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

12:05
02/20/19
02/20
12:05
02/20/19
12:05
General news
U.S. corporate bond update: the calendar remains active. »

U.S. corporate bond…

DNLI

Denali Therapeutics

$21.44

-0.16 (-0.74%)

12:03
02/20/19
02/20
12:03
02/20/19
12:03
Hot Stocks
Denali granted orphan status for mucopolysaccharidosis treatment »

The FDA granted Denali…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDY

Dr. Reddy's

$35.97

-0.45 (-1.24%)

12:03
02/20/19
02/20
12:03
02/20/19
12:03
Hot Stocks
Dr. Reddy's announces re-launch of buprenorphine, naloxone sublingual film »

Dr. Reddy's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

HSY

Hershey

$109.86

0.165 (0.15%)

12:01
02/20/19
02/20
12:01
02/20/19
12:01
Earnings
Hershey backs FY19 adjusted EPS growth view of 5%-7%, consensus $5.64 »

Backs FY19 net sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 03

    Mar

QTT

Qutoutiao

$12.66

0.25 (2.01%)

12:01
02/20/19
02/20
12:01
02/20/19
12:01
Downgrade
Qutoutiao rating change  »

Qutoutiao downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

BHC

Bausch Health

$23.23

-1.94 (-7.71%)

12:00
02/20/19
02/20
12:00
02/20/19
12:00
Hot Stocks
Bausch Health falls -7.7% »

Bausch Health is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 12

    Mar

  • 12

    Mar

IDT

IDT Corp

$6.48

-0.68 (-9.50%)

12:00
02/20/19
02/20
12:00
02/20/19
12:00
Hot Stocks
IDT Corp falls -9.1% »

IDT Corp is down -9.1%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMI

Owens & Minor

$6.62

-1.32 (-16.62%)

12:00
02/20/19
02/20
12:00
02/20/19
12:00
Hot Stocks
Owens & Minor falls -16.6% »

Owens & Minor is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.